BIENAIME JEAN JACQUES
Insider CIK 1221590 · BMRN Chief Executive Officer, Director · ITMN Director · PTLA Director · VTL Director · NGSX Director · IMNM Director · ASND Director · KROS Director · INCY Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KROS Keros Therapeutics, Inc. | P Buy | 2026-08-17 | 2026-08-19 | 1,000 | $10.27 | $10.3K | 19,592 | SEC↗ |
| KROS Keros Therapeutics, Inc. | P Buy | 2026-08-17 | 2026-08-19 | 1,000 | $10.27 | $10.3K | 19,592 | SEC↗ |
| ASND Ascendis Pharma A/S | P Buy | 2026-08-14 | 2026-08-18 | 900 | $246.91 | $222.2K | 2,900 | SEC↗ |
| ASND Ascendis Pharma A/S | P Buy | 2026-08-14 | 2026-08-18 | 1,100 | $245.85 | $270.4K | 2,000 | SEC↗ |
| ASND Ascendis Pharma A/S | P Buy | 2026-08-14 | 2026-08-18 | 900 | $246.91 | $222.2K | 2,900 | SEC↗ |
| ASND Ascendis Pharma A/S | P Buy | 2026-08-14 | 2026-08-18 | 1,100 | $245.85 | $270.4K | 2,000 | SEC↗ |
| KROS Keros Therapeutics, Inc. | P Buy | 2026-07-15 | 2026-07-17 | 1,000 | $10.61 | $10.6K | 18,592 | SEC↗ |
| KROS Keros Therapeutics, Inc. | P Buy | 2026-06-15 | 2026-06-17 | 1,000 | $10.19 | $10.2K | 17,592 | SEC↗ |
| IMNM Immunome Inc. | A Award deriv | 2026-06-10 | 2026-06-12 | 9,897 | — | $0 | 9,897 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2026-06-08 | 2026-06-10 | 6,111 | — | $0 | 6,111 | SEC↗ |
| INCY INCYTE CORP | A Award | 2026-06-08 | 2026-06-10 | 1,642 | — | $0 | 24,424 | SEC↗ |
| IMNM Immunome Inc. | P Buy | 2026-06-05 | 2026-06-09 | 1,000 | $19.27 | $19.3K | 43,415 | SEC↗ |
| IMNM Immunome Inc. | P Buy | 2026-06-05 | 2026-06-09 | 3,500 | $19.46 | $68.1K | 42,415 | SEC↗ |
| IMNM Immunome Inc. | P Buy | 2026-06-05 | 2026-06-09 | 6,000 | $19.48 | $116.9K | 38,915 | SEC↗ |
| IMNM Immunome Inc. | S Sale | 2026-06-05 | 2026-06-09 | 10,000 | $19.41 | $194.1K | 32,915 | SEC↗ |
| IMNM Immunome Inc. | S Sale | 2026-06-05 | 2026-06-09 | 500 | $19.44 | $9.7K | 42,915 | SEC↗ |
| KROS Keros Therapeutics, Inc. | A Award deriv | 2026-06-03 | 2026-06-05 | 7,433 | — | $0 | 7,433 | SEC↗ |
| KROS Keros Therapeutics, Inc. | A Award | 2026-06-03 | 2026-06-05 | 7,142 | — | $0 | 16,592 | SEC↗ |
| ASND Ascendis Pharma A/S | P Buy | 2026-05-29 | 2026-06-01 | 200 | $222.30 | $44.5K | 800 | SEC↗ |
| ASND Ascendis Pharma A/S | P Buy | 2026-05-29 | 2026-06-01 | 100 | $223.50 | $22.4K | 900 | SEC↗ |
| ASND Ascendis Pharma A/S | P Buy | 2026-05-29 | 2026-06-01 | 200 | $223.76 | $44.8K | 600 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2026-05-26 | 2026-05-28 | 15,000 | — | $0 | 0 | SEC↗ |
| ASND Ascendis Pharma A/S | P Buy | 2026-05-26 | 2026-05-27 | 200 | $236.24 | $47.2K | 200 | SEC↗ |
| ASND Ascendis Pharma A/S | P Buy | 2026-05-26 | 2026-05-27 | 200 | $239.37 | $47.9K | 400 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2026-05-26 | 2026-05-28 | 15,000 | $84.53 | $1.27M | 35,841 | SEC↗ |
| INCY INCYTE CORP | F Tax w/h | 2026-05-26 | 2026-05-28 | 13,059 | $97.10 | $1.27M | 22,782 | SEC↗ |
| IMNM Immunome Inc. | P Buy | 2026-05-15 | 2026-05-19 | 5,000 | $20.70 | $103.5K | 43,415 | SEC↗ |
| KROS Keros Therapeutics, Inc. | P Buy | 2026-05-15 | 2026-05-19 | 1,000 | $10.58 | $10.6K | 9,450 | SEC↗ |
| KROS Keros Therapeutics, Inc. | P Buy | 2026-04-15 | 2026-04-17 | 1,000 | $11.70 | $11.7K | 8,450 | SEC↗ |
| ASND Ascendis Pharma A/S | D To issuer deriv | 2026-04-14 | 2026-09-28 | 9,160 | — | $0 | 0 | SEC↗ |
| ASND Ascendis Pharma A/S | A Award deriv | 2026-04-14 | 2026-09-28 | 9,160 | — | $0 | 9,160 | SEC↗ |
| ASND Ascendis Pharma A/S | A Award deriv | 2026-04-14 | 2026-09-28 | 9,160 | — | — | 9,160 | SEC↗ |
| ASND Ascendis Pharma A/S | D To issuer deriv | 2026-04-14 | 2026-09-28 | 9,160 | — | — | 0 | SEC↗ |
| IMNM Immunome Inc. | P Buy | 2026-03-11 | 2026-03-12 | 1,000 | $21.55 | $21.6K | 38,415 | SEC↗ |
| IMNM Immunome Inc. | P Buy | 2026-03-10 | 2026-03-12 | 1,000 | $22.12 | $22.1K | 37,415 | SEC↗ |
| KROS Keros Therapeutics, Inc. | P Buy | 2026-03-09 | 2026-03-11 | 2,000 | $11.21 | $22.4K | 7,450 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2025-06-10 | 2025-06-12 | 9,216 | — | $0 | 9,216 | SEC↗ |
| IMNM Immunome Inc. | A Award deriv | 2025-06-10 | 2025-06-12 | 18,864 | — | $0 | 18,864 | SEC↗ |
| INCY INCYTE CORP | A Award | 2025-06-10 | 2025-06-12 | 2,518 | — | $0 | 20,841 | SEC↗ |
| KROS Keros Therapeutics, Inc. | A Award deriv | 2025-06-04 | 2025-06-06 | 10,500 | — | $0 | 10,500 | SEC↗ |
| KROS Keros Therapeutics, Inc. | A Award | 2025-06-04 | 2025-06-06 | 5,250 | — | $0 | 5,450 | SEC↗ |
| IMNM Immunome Inc. | P Buy | 2025-06-03 | 2025-06-03 | 5,000 | $9.38 | $46.9K | 36,415 | SEC↗ |
| IMNM Immunome Inc. | P Buy | 2025-03-25 | 2025-03-26 | 7,800 | $7.78 | $60.7K | 31,415 | SEC↗ |
| IMNM Immunome Inc. | P Buy | 2025-03-24 | 2025-03-25 | 7,000 | $8.21 | $57.5K | 23,615 | SEC↗ |
| IMNM Immunome Inc. | P Buy | 2024-08-16 | 2024-08-19 | 7,000 | $13.94 | $97.6K | 16,615 | SEC↗ |
| IMNM Immunome Inc. | A Award deriv | 2024-06-13 | 2024-06-18 | 11,333 | — | $0 | 11,333 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2024-06-12 | 2024-06-14 | 12,517 | — | $0 | 12,517 | SEC↗ |
| INCY INCYTE CORP | A Award | 2024-06-12 | 2024-06-14 | 2,830 | — | $0 | 18,323 | SEC↗ |
| KROS Keros Therapeutics, Inc. | A Award deriv | 2024-06-03 | 2024-06-05 | 17,600 | — | $0 | 17,600 | SEC↗ |
| IMNM Immunome Inc. | P Buy | 2024-05-21 | 2024-05-22 | 2,000 | $13.57 | $27.1K | 9,615 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2024-05-20 | 2024-05-21 | 1,202 | $77.05 | $92.6K | 473,792 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2024-05-10 | 2024-05-13 | 20,000 | — | $0 | 51,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2024-05-10 | 2024-05-13 | 20,000 | $63.10 | $1.26M | 494,994 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2024-05-10 | 2024-05-13 | 20,000 | $81.14 | $1.62M | 474,994 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2024-05-09 | 2024-05-13 | 20,000 | — | $0 | 71,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2024-05-09 | 2024-05-13 | 20,000 | $63.10 | $1.26M | 494,994 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2024-05-09 | 2024-05-13 | 20,000 | $81.62 | $1.63M | 474,994 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2024-04-12 | 2024-04-15 | 20,000 | — | $0 | 91,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2024-04-12 | 2024-04-15 | 20,000 | $63.10 | $1.26M | 494,994 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2024-04-12 | 2024-04-15 | 20,000 | $91.26 | $1.83M | 474,994 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2024-04-11 | 2024-04-15 | 20,000 | — | $0 | 111,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2024-04-11 | 2024-04-15 | 20,000 | $90.99 | $1.82M | 474,994 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2024-04-11 | 2024-04-15 | 20,000 | $63.10 | $1.26M | 494,994 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2024-03-15 | 2024-03-19 | 85,209 | $83.87 | $7.15M | 474,994 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2024-03-06 | 2024-03-07 | 1,000 | $86.71 | $86.7K | 560,203 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2024-03-05 | 2024-03-07 | 1,000 | $85.51 | $85.5K | 561,203 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2024-02-27 | 2024-02-29 | 1,000 | $90.35 | $90.3K | 562,203 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2024-02-27 | 2024-02-29 | 24,926 | — | $0 | 563,203 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2024-02-27 | 2024-02-29 | 82,700 | — | $0 | 502,302 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2024-02-27 | 2024-02-29 | 35,975 | — | $0 | 538,277 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2024-02-09 | 2024-02-12 | 15,000 | — | $0 | 131,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2024-02-09 | 2024-02-12 | 15,000 | $88.28 | $1.32M | 419,602 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2024-02-09 | 2024-02-12 | 15,000 | $63.10 | $946.5K | 434,602 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2024-02-08 | 2024-02-12 | 15,000 | — | $0 | 146,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2024-02-08 | 2024-02-12 | 15,000 | $89.77 | $1.35M | 419,602 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2024-02-08 | 2024-02-12 | 15,000 | $63.10 | $946.5K | 434,602 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | L Small acq | 2024-01-18 | 2024-02-12 | 40 | $92.60 | $3.7K | 419,602 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2024-01-10 | 2024-01-11 | 10,000 | — | $0 | 161,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2024-01-10 | 2024-01-11 | 10,000 | $96.38 | $963.8K | 425,162 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2024-01-10 | 2024-01-11 | 10,000 | $63.10 | $631.0K | 435,162 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2024-01-09 | 2024-01-11 | 10,000 | — | $0 | 171,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2024-01-09 | 2024-01-11 | 10,000 | $98.19 | $981.9K | 425,162 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2024-01-09 | 2024-01-11 | 10,000 | $63.10 | $631.0K | 435,162 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | L Small acq | 2024-01-08 | 2024-01-11 | 50 | $99.05 | $5.0K | 425,162 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2023-12-21 | 2023-12-22 | 10,000 | — | $0 | 181,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2023-12-21 | 2023-12-22 | 10,000 | $93.99 | $939.9K | 425,112 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2023-12-21 | 2023-12-22 | 10,000 | $63.10 | $631.0K | 435,112 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2023-12-01 | 2023-12-12 | 2,370 | — | $0 | 425,112 | SEC↗ |
| IMNM Immunome Inc. | A Award deriv | 2023-11-07 | 2023-11-09 | 40,696 | — | $0 | 40,696 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | L Small acq | 2023-10-04 | 2023-12-12 | 10 | $85.57 | $856 | 422,742 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2023-08-08 | 2023-08-09 | 6,000 | $88.29 | $529.7K | 422,732 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2023-08-07 | 2023-08-09 | 4,000 | $88.10 | $352.4K | 428,732 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2023-06-14 | 2023-06-16 | 11,294 | — | $0 | 11,294 | SEC↗ |
| INCY INCYTE CORP | A Award | 2023-06-14 | 2023-06-16 | 2,505 | — | $0 | 15,493 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2023-05-12 | 2023-05-16 | 7,370 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2023-05-12 | 2023-05-16 | 39,130 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2023-05-12 | 2023-05-16 | 6,337 | $93.93 | $595.2K | 466,376 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2023-05-12 | 2023-05-16 | 33,644 | $93.93 | $3.16M | 432,732 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2023-05-12 | 2023-05-16 | 39,130 | $67.81 | $2.65M | 465,343 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2023-05-12 | 2023-05-16 | 7,370 | $67.81 | $499.8K | 472,713 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2023-05-11 | 2023-05-15 | 30,000 | — | $0 | 39,130 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2023-05-11 | 2023-05-15 | 24,439 | $94.55 | $2.31M | 431,774 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2023-05-11 | 2023-05-15 | 30,000 | $67.81 | $2.03M | 456,213 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2023-05-11 | 2023-05-15 | 5,561 | $95.22 | $529.5K | 426,213 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2023-05-10 | 2023-05-11 | 8,547 | $95.34 | $814.9K | 426,213 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2023-05-10 | 2023-05-11 | 21,453 | $94.65 | $2.03M | 434,760 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2023-05-10 | 2023-05-11 | 30,000 | $67.81 | $2.03M | 456,213 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2023-05-09 | 2023-05-11 | 30,000 | — | $0 | 69,130 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2023-05-09 | 2023-05-11 | 30,000 | — | $0 | 99,130 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2023-05-09 | 2023-05-11 | 1,410 | $95.90 | $135.2K | 426,213 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2023-05-09 | 2023-05-11 | 14,964 | $95.49 | $1.43M | 427,623 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2023-05-09 | 2023-05-11 | 13,626 | $94.22 | $1.28M | 442,587 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2023-05-09 | 2023-05-11 | 30,000 | $67.81 | $2.03M | 456,213 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2023-04-28 | 2023-05-11 | 317 | $66.88 | $21.2K | 426,213 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2023-04-10 | 2023-04-12 | 10,000 | — | $0 | 129,130 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2023-04-10 | 2023-04-12 | 10,000 | $67.81 | $678.1K | 435,896 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2023-04-10 | 2023-04-12 | 10,000 | $99.56 | $995.6K | 425,896 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2023-04-06 | 2023-04-10 | 10,000 | — | $0 | 139,130 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2023-04-06 | 2023-04-10 | 10,000 | $67.81 | $678.1K | 435,896 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2023-04-06 | 2023-04-10 | 10,000 | $96.13 | $961.3K | 425,896 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2023-03-16 | 2023-03-17 | 88,623 | $93.41 | $8.28M | 425,896 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2023-03-15 | 2023-03-17 | 49,430 | — | $0 | 49,430 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2023-03-15 | 2023-03-17 | 9,437 | $87.74 | $828.0K | 514,519 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2023-03-15 | 2023-03-17 | 36,100 | — | $0 | 523,956 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2023-03-13 | 2023-03-14 | 8,000 | — | $0 | 149,130 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2023-03-13 | 2023-03-14 | 8,000 | $90.45 | $723.6K | 487,856 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2023-03-13 | 2023-03-14 | 8,000 | $67.81 | $542.5K | 495,856 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2023-03-10 | 2023-03-14 | 15,000 | — | $0 | 157,130 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2023-03-10 | 2023-03-14 | 15,000 | $67.81 | $1.02M | 502,856 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2023-03-10 | 2023-03-14 | 15,000 | $92.28 | $1.38M | 487,856 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2023-02-28 | 2023-03-02 | 32,972 | — | $0 | 487,856 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2023-02-28 | 2023-03-02 | 89,700 | — | $0 | 410,024 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2023-02-28 | 2023-03-02 | 44,860 | — | $0 | 454,884 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2023-02-13 | 2023-02-14 | 6,000 | $109.15 | $654.9K | 320,324 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2023-02-13 | 2023-02-14 | 6,000 | $67.81 | $406.9K | 326,324 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2023-02-10 | 2023-02-14 | 6,000 | — | $0 | 172,130 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2023-02-10 | 2023-02-14 | 15,000 | — | $0 | 178,130 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2023-02-10 | 2023-02-14 | 15,000 | $67.81 | $1.02M | 335,324 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2023-02-10 | 2023-02-14 | 15,000 | $110.11 | $1.65M | 320,324 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | G Gift | 2023-02-07 | 2023-02-14 | 200 | — | $0 | 247,333 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | G Gift | 2023-02-07 | 2023-02-14 | 100 | — | $0 | 100 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | G Gift | 2023-02-07 | 2023-02-14 | 100 | — | $0 | 100 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2023-01-17 | 2023-01-18 | 10,000 | — | $0 | 193,130 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2023-01-17 | 2023-01-18 | 10,000 | $111.55 | $1.12M | 320,424 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2023-01-17 | 2023-01-18 | 10,000 | $67.81 | $678.1K | 330,424 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2023-01-13 | 2023-01-18 | 10,000 | — | $0 | 203,130 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2023-01-13 | 2023-01-18 | 10,000 | $112.25 | $1.12M | 320,424 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2023-01-13 | 2023-01-18 | 10,000 | $67.81 | $678.1K | 330,424 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2022-12-13 | 2022-12-15 | 1,000 | $106.89 | $106.9K | 320,424 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2022-12-02 | 2022-12-06 | 69 | $104.06 | $7.2K | 321,424 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2022-12-02 | 2022-12-06 | 100 | $104.00 | $10.4K | 321,493 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2022-12-02 | 2022-12-06 | 260 | $103.98 | $27.0K | 321,593 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2022-12-02 | 2022-12-06 | 600 | $103.97 | $62.4K | 321,853 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2022-12-02 | 2022-12-06 | 471 | $103.97 | $49.0K | 322,453 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | L Small acq | 2022-11-02 | 2022-12-06 | 100 | $86.12 | $8.6K | 322,924 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2022-10-31 | 2022-11-01 | 1,500 | $86.55 | $129.8K | 322,824 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2022-10-14 | 2022-10-18 | 4,000 | $89.89 | $359.6K | 324,324 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2022-08-15 | 2022-08-16 | 3,000 | $95.21 | $285.6K | 328,324 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2022-08-12 | 2022-08-16 | 4,000 | $94.75 | $379.0K | 331,324 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2022-06-15 | 2022-06-17 | 9,124 | — | $0 | 9,124 | SEC↗ |
| INCY INCYTE CORP | A Award | 2022-06-15 | 2022-06-17 | 2,144 | — | $0 | 12,988 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2022-05-06 | 2022-05-09 | 20,000 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2022-05-06 | 2022-05-09 | 20,000 | $81.00 | $1.62M | 335,324 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2022-05-06 | 2022-05-09 | 20,000 | $37.46 | $749.2K | 355,324 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2022-05-05 | 2022-05-09 | 10,000 | — | $0 | 20,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2022-05-05 | 2022-05-09 | 10,000 | $37.46 | $374.6K | 345,324 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2022-05-05 | 2022-05-09 | 10,000 | $84.14 | $841.4K | 335,324 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2022-04-29 | 2022-05-02 | 5,000 | — | $0 | 30,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2022-04-29 | 2022-05-02 | 5,000 | $81.95 | $409.8K | 334,983 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2022-04-29 | 2022-05-02 | 5,000 | $37.46 | $187.3K | 339,983 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2022-04-29 | 2022-05-09 | 341 | $62.41 | $21.3K | 335,324 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2022-04-28 | 2022-05-02 | 20,000 | — | $0 | 35,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2022-04-28 | 2022-05-02 | 20,000 | $37.46 | $749.2K | 354,983 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2022-04-28 | 2022-05-02 | 20,000 | $83.79 | $1.68M | 334,983 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2022-04-18 | 2022-04-20 | 20,000 | — | $0 | 55,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2022-04-18 | 2022-04-20 | 20,000 | $37.46 | $749.2K | 354,983 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2022-04-18 | 2022-04-20 | 20,000 | $81.91 | $1.64M | 334,983 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2022-04-14 | 2022-04-18 | 10,000 | — | $0 | 75,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2022-04-14 | 2022-04-18 | 10,000 | $83.66 | $836.6K | 334,983 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2022-04-14 | 2022-04-18 | 10,000 | $37.46 | $374.6K | 344,983 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2022-03-16 | 2022-03-17 | 5,560 | $80.72 | $448.8K | 334,983 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2022-03-15 | 2022-03-17 | 58,040 | — | $0 | 58,040 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2022-03-15 | 2022-03-17 | 38,306 | $78.27 | $3.00M | 340,543 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2022-03-15 | 2022-03-17 | 40,280 | — | $0 | 378,849 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2022-03-11 | 2022-03-14 | 15,000 | — | $0 | 85,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2022-03-11 | 2022-03-14 | 15,000 | $37.46 | $561.9K | 353,569 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2022-03-11 | 2022-03-14 | 15,000 | $77.81 | $1.17M | 338,569 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2022-03-10 | 2022-03-14 | 15,000 | — | $0 | 100,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2022-03-10 | 2022-03-14 | 15,000 | $77.57 | $1.16M | 338,569 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2022-03-10 | 2022-03-14 | 15,000 | $37.46 | $561.9K | 353,569 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2022-03-08 | 2022-03-10 | 34,780 | — | $0 | 338,569 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2022-01-13 | 2022-01-14 | 5,000 | — | $0 | 115,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2022-01-13 | 2022-01-14 | 5,000 | $37.46 | $187.3K | 308,789 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2022-01-13 | 2022-01-14 | 5,000 | $87.86 | $439.3K | 303,789 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2022-01-12 | 2022-01-14 | 5,000 | — | $0 | 120,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2022-01-12 | 2022-01-14 | 5,000 | $89.00 | $445.0K | 303,789 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2022-01-12 | 2022-01-14 | 5,000 | $37.46 | $187.3K | 308,789 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | L Small acq | 2021-12-21 | 2022-01-14 | 100 | $89.22 | $8.9K | 303,789 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2021-12-16 | 2021-12-17 | 6,000 | — | $0 | 125,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2021-12-16 | 2021-12-17 | 6,000 | $37.46 | $224.8K | 309,689 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2021-12-16 | 2021-12-17 | 6,000 | $84.68 | $508.1K | 303,689 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2021-12-15 | 2021-12-17 | 6,000 | — | $0 | 131,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2021-12-15 | 2021-12-17 | 6,000 | $37.46 | $224.8K | 309,689 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2021-12-15 | 2021-12-17 | 6,000 | $82.71 | $496.3K | 303,689 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | G Gift | 2021-12-10 | 2021-12-17 | 700 | — | $0 | 303,689 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2021-12-01 | 2021-12-02 | 1,500 | $87.22 | $130.8K | 304,389 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2021-10-20 | 2021-10-22 | 1,000 | — | $0 | 137,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2021-10-20 | 2021-10-22 | 1,000 | $37.46 | $37.5K | 305,839 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | L Small acq | 2021-09-09 | 2021-12-02 | 50 | $78.77 | $3.9K | 305,889 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2021-06-21 | 2021-06-23 | 1,000 | — | $0 | 138,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2021-06-21 | 2021-06-23 | 1,000 | $37.46 | $37.5K | 304,839 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2021-05-26 | 2021-05-28 | 8,010 | — | $0 | 8,010 | SEC↗ |
| INCY INCYTE CORP | A Award | 2021-05-26 | 2021-05-28 | 1,923 | — | $0 | 10,844 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2021-05-10 | 2021-05-12 | 8,513 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2021-05-10 | 2021-05-12 | 8,513 | $26.49 | $225.5K | 312,352 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2021-05-10 | 2021-05-12 | 8,513 | $77.29 | $658.0K | 303,839 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2021-05-07 | 2021-05-10 | 25,000 | — | $0 | 8,513 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2021-05-07 | 2021-05-10 | 6,115 | $78.77 | $481.7K | 307,168 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2021-05-07 | 2021-05-10 | 15,556 | $77.60 | $1.21M | 313,283 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2021-05-07 | 2021-05-10 | 25,000 | $26.49 | $662.3K | 328,839 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2021-05-07 | 2021-05-10 | 3,329 | $79.39 | $264.3K | 303,839 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2021-05-06 | 2021-05-10 | 25,000 | — | $0 | 33,513 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2021-05-06 | 2021-05-10 | 14,825 | $78.01 | $1.16M | 314,014 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2021-05-06 | 2021-05-10 | 25,000 | $26.49 | $662.3K | 328,839 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2021-05-06 | 2021-05-10 | 10,175 | $78.69 | $800.7K | 303,839 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2021-04-30 | 2021-05-03 | 1,000 | — | $0 | 139,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2021-04-30 | 2021-05-03 | 1,000 | $37.46 | $37.5K | 303,498 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2021-04-30 | 2021-05-10 | 341 | $62.41 | $21.3K | 303,839 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2021-04-23 | 2021-04-26 | 10,000 | — | $0 | 58,513 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2021-04-23 | 2021-04-26 | 10,000 | $26.49 | $264.9K | 312,498 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2021-04-23 | 2021-04-26 | 10,000 | $79.34 | $793.4K | 302,498 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2021-04-22 | 2021-04-26 | 10,000 | — | $0 | 68,513 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2021-04-22 | 2021-04-26 | 10,000 | $78.91 | $789.1K | 302,498 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2021-04-22 | 2021-04-26 | 10,000 | $26.49 | $264.9K | 312,498 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2021-03-22 | 2021-03-23 | 5,519 | $78.52 | $433.4K | 302,498 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2021-03-16 | 2021-03-17 | 5,559 | $77.21 | $429.2K | 308,017 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2021-03-15 | 2021-03-17 | 101,820 | — | $0 | 101,820 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2021-03-15 | 2021-03-17 | 41,350 | — | $0 | 337,002 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2021-03-15 | 2021-03-17 | 23,426 | $78.39 | $1.84M | 313,576 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2021-03-12 | 2021-03-15 | 7,000 | — | $0 | 78,513 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2021-03-12 | 2021-03-15 | 7,000 | $26.49 | $185.4K | 302,652 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2021-03-12 | 2021-03-15 | 7,000 | $77.10 | $539.7K | 295,652 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2021-03-11 | 2021-03-15 | 7,000 | — | $0 | 85,513 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2021-03-11 | 2021-03-15 | 7,000 | $77.68 | $543.8K | 295,652 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2021-03-11 | 2021-03-15 | 7,000 | $26.49 | $185.4K | 302,652 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | L Small acq | 2021-03-04 | 2021-03-15 | 100 | $77.94 | $7.8K | 295,652 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2021-02-19 | 2021-02-22 | 7,000 | — | $0 | 92,513 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2021-02-19 | 2021-02-22 | 7,000 | $26.49 | $185.4K | 302,552 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2021-02-19 | 2021-02-22 | 7,000 | $83.58 | $585.1K | 295,552 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2021-02-18 | 2021-02-19 | 7,000 | — | $0 | 99,513 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2021-02-18 | 2021-02-19 | 7,000 | $85.08 | $595.6K | 295,552 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2021-02-18 | 2021-02-19 | 7,000 | $26.49 | $185.4K | 302,552 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2021-02-17 | 2021-02-18 | 8,000 | — | $0 | 106,513 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2021-02-17 | 2021-02-18 | 8,000 | $84.54 | $676.3K | 295,552 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2021-02-17 | 2021-02-18 | 8,000 | $26.49 | $211.9K | 303,552 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2021-01-29 | 2021-02-01 | 8,334 | — | $0 | 114,513 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2021-01-29 | 2021-02-01 | 8,334 | $82.67 | $689.0K | 295,552 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2021-01-29 | 2021-02-01 | 8,334 | $26.49 | $220.8K | 303,886 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2021-01-28 | 2021-02-01 | 8,333 | — | $0 | 122,847 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2021-01-28 | 2021-02-01 | 8,333 | $82.91 | $690.9K | 295,552 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2021-01-28 | 2021-02-01 | 8,333 | $26.49 | $220.7K | 303,885 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2021-01-27 | 2021-01-28 | 8,333 | — | $0 | 131,180 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2021-01-27 | 2021-01-28 | 8,333 | $26.49 | $220.7K | 303,885 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2021-01-27 | 2021-01-28 | 8,333 | $85.49 | $712.4K | 295,552 | SEC↗ |
| INCY INCYTE CORP | A Award | 2020-12-31 | 2021-01-05 | 275 | $86.98 | $23.9K | 8,921 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2020-12-29 | 2020-12-30 | 1,500 | $88.18 | $132.3K | 295,552 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2020-12-28 | 2020-12-30 | 1,500 | $88.77 | $133.2K | 297,052 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2020-11-10 | 2020-11-12 | 798 | $83.00 | $66.2K | 8,646 | SEC↗ |
| INCY INCYTE CORP | A Award | 2020-09-30 | 2020-10-01 | 254 | $89.74 | $22.8K | 9,444 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | G Gift | 2020-07-09 | 2020-12-30 | 425 | — | $0 | 247,533 | SEC↗ |
| INCY INCYTE CORP | A Award | 2020-06-30 | 2020-07-01 | 208 | $103.97 | $21.6K | 9,190 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2020-05-26 | 2020-05-28 | 10,514 | — | $0 | 10,514 | SEC↗ |
| INCY INCYTE CORP | A Award | 2020-05-26 | 2020-05-28 | 1,282 | — | $0 | 8,982 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2020-05-08 | 2020-05-12 | 20,000 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2020-05-08 | 2020-05-12 | 20,000 | $91.72 | $1.83M | 298,552 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2020-05-08 | 2020-05-12 | 20,000 | $21.51 | $430.2K | 318,552 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2020-05-04 | 2020-05-05 | 5,000 | — | $0 | 20,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2020-05-04 | 2020-05-05 | 5,000 | $21.51 | $107.6K | 303,552 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2020-05-04 | 2020-05-05 | 5,000 | $88.00 | $440.0K | 298,552 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2020-05-01 | 2020-05-05 | 4,000 | — | $0 | 25,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2020-05-01 | 2020-05-05 | 4,000 | $89.38 | $357.5K | 298,552 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2020-05-01 | 2020-05-05 | 4,000 | $21.51 | $86.0K | 302,552 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2020-04-30 | 2020-05-05 | 339 | $62.59 | $21.2K | 298,552 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2020-04-28 | 2020-04-29 | 20,000 | — | $0 | 29,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2020-04-28 | 2020-04-29 | 20,000 | $21.51 | $430.2K | 318,213 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2020-04-28 | 2020-04-29 | 20,000 | $97.58 | $1.95M | 298,213 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2020-04-27 | 2020-04-29 | 20,000 | — | $0 | 49,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2020-04-27 | 2020-04-29 | 20,000 | $21.51 | $430.2K | 318,213 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2020-04-27 | 2020-04-29 | 20,000 | $97.73 | $1.95M | 298,213 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2020-04-09 | 2020-04-13 | 10,000 | — | $0 | 69,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2020-04-09 | 2020-04-13 | 10,000 | $21.51 | $215.1K | 308,213 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2020-04-09 | 2020-04-13 | 10,000 | $79.06 | $790.6K | 298,213 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2020-04-07 | 2020-04-08 | 1,000 | — | $0 | 139,513 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2020-04-07 | 2020-04-08 | 1,000 | $26.49 | $26.5K | 298,213 | SEC↗ |
| INCY INCYTE CORP | A Award | 2020-03-31 | 2020-04-02 | 236 | $73.23 | $17.3K | 7,700 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2020-03-20 | 2020-03-24 | 13,128 | $73.05 | $959.0K | 297,213 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2020-03-16 | 2020-03-17 | 127,920 | — | $0 | 127,920 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2020-03-16 | 2020-03-17 | 44,850 | — | $0 | 310,341 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2020-03-13 | 2020-03-17 | 30,952 | $84.50 | $2.62M | 265,491 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2020-03-09 | 2020-03-11 | 10,000 | — | $0 | 79,000 | SEC↗ |